Vivos Therapeutics Inc (VVOS) Enterprise Value to EBITDA Ratio
Assembly capacities for dental equipment are operating seamlessly while adhering to strict quality standards, although slow market penetration and insurance reimbursement challenges are hindering expansion. This chart of the share price, featuring the 0.00 indicator, confirms the potential of Vivos Therapeutics (VVOS), as certified apnea treatment methods generate a steady profit stream through the recurring sale of software and consumables.
Comprehensive metric breakdowns and analytics for vivoslife.com (VVOS)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Vivos Therapeutics|VVOS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Vivos Therapeutics, Inc.|VVOS - Company Total Debt|Debts to Book Capitalization Vivos Therapeutics Inc|VVOS - Long-Term Debt|Company Short-Term Debts Vivos Therapeutics|Quick Ratio vivoslife.com
- financial results and valuation multiples details:
VVOS - Net Financial Result|Projected Future Earnings Vivos Therapeutics|VVOS - Price to Earnings Ratio|Forward P/E Multiple Vivos Therapeutics|VVOS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics Inc|VVOS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Vivos Therapeutics|VVOS - Earnings per share for the trailing year|Quarterly EPS earnings growth vivoslife.com|VVOS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Vivos Therapeutics
Analysis of all company metrics:Vivos Therapeutics, Inc VVOS
The EV/EBITDA ratio compares the total enterprise value, including debt, with operating profit before depreciation and amortization. By analyzing changes in the EV to EBITDA ratio, an investor assesses the efficiency of capital return, which is critical for Vivos Therapeutics (VVOS) as it implements costly eco-friendly polymers and energy-efficient technologies in the production of apnea treatment devices.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MODD|MYO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envoy Medical COCH|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD (ReWalk Robotics Ltd.) - Enterprise Value to EBITDA Ratio|AMIX (Autonomix Medical) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IVF (INVO Fertility) - EV/EBITDA Multiple|Bone Biologics Corp. (BBLG) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BIOL (Biolase Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics DYNT|Paragon 28 Inc. (FNA) - Company Value to EBITDA|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
